# OR2M2

## Overview
The OR2M2 gene encodes the protein olfactory receptor family 2 subfamily M member 2, which is a member of the G-protein-coupled receptor (GPCR) superfamily. These receptors are integral membrane proteins that play a pivotal role in the detection and transduction of odorant signals in the olfactory system (Yin2020Functional). OR2M2 is primarily expressed in the olfactory epithelium, where it binds specific odor molecules, initiating a signaling cascade that ultimately leads to the perception of smell. Beyond its traditional role in olfaction, OR2M2 and other olfactory receptors have been found in various non-olfactory tissues, suggesting additional physiological roles that are not yet fully understood (Tong2021Ectopic). The gene has also been implicated in certain pathological conditions, such as head and neck squamous cell carcinoma, highlighting its potential clinical significance (Bai2019A).

## Function
The OR2M2 gene encodes an olfactory receptor that is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in the detection of odor molecules. These receptors are primarily expressed in the olfactory epithelium, where they bind specific odorants and initiate a signal transduction cascade that results in the perception of smell (Yin2020Functional). The olfactory transduction pathway involves the activation of a signaling cascade that includes Gα olf, Adcy3, and cAMP, which are essential for odorant detection (Tong2021Ectopic).

In addition to their role in olfactory signaling, olfactory receptors, including OR2M2, have been identified in non-olfactory tissues, suggesting potential roles beyond the sense of smell. These ectopic expressions have been implicated in various physiological and pathological processes, such as cancer growth and metabolic regulation (Tong2021Ectopic). However, specific functional information about OR2M2 in healthy human cells remains limited, and its precise roles in non-olfactory tissues are not well understood (Jin2018Aberrant). The gene has been identified as a hub protein in protein-protein interaction networks, indicating its potential importance in certain biological contexts, such as hepatitis B virus infection (Jin2018Aberrant).

## Clinical Significance
The OR2M2 gene, part of the olfactory receptor family, has been associated with various clinical implications, particularly in head and neck squamous cell carcinoma (HNSCC). Studies have shown that mutations in OR2M2 are significantly enriched in HNSCC cases with a higher SIG12 score, which correlates with poor prognosis. This suggests a potential link between OR2M2 mutations and adverse outcomes in HNSCC patients (Bai2019A).

In the context of pseudoxanthoma elasticum (PXE), OR2M2 is mentioned as part of the signaling pathways involving G protein-coupled receptors (GPCRs), which are implicated in modulating the severity of cardiovascular disease associated with PXE. However, specific diseases or conditions directly related to OR2M2 mutations or expression alterations in PXE are not detailed (De2021Rare).

While OR2M2 is involved in olfactory transduction pathways, the specific impact of its mutations or expression changes on diseases related to olfactory function is not extensively documented. The gene's role in olfactory signaling suggests that alterations could potentially affect the sense of smell, but direct clinical associations remain to be fully elucidated (Yin2020Functional).


## References


[1. (Bai2019A) Shuang Bai, Ping Zhang, Jian‐Cheng Zhang, Jun Shen, Xu Xiang, Ying‐Bin Yan, Zhen‐Qi Xu, Jun Zhang, Li Long, Chao Wang, Ping Shi, Li Yang, Wei Chen, and Hao Liu. A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma. Head &amp; Neck, 41(8):2581–2590, March 2019. URL: http://dx.doi.org/10.1002/hed.25731, doi:10.1002/hed.25731. This article has 12 citations.](https://doi.org/10.1002/hed.25731)

[2. (Tong2021Ectopic) Tao Tong, Yanan Wang, Seong-Gook Kang, and Kunlun Huang. Ectopic odorant receptor responding to flavor compounds: versatile roles in health and disease. Pharmaceutics, 13(8):1314, August 2021. URL: http://dx.doi.org/10.3390/pharmaceutics13081314, doi:10.3390/pharmaceutics13081314. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/pharmaceutics13081314)

[3. (Yin2020Functional) Shang-Jun Yin, Min-Woo Park, Bit-Na Lee, Jun-Mo Yang, Yong-Doo Park, and Guo-Ying Qian. Functional study of acetaldehyde dehydrogenase 1 (aldh1) in keratinocytes: microarray integrating bioinformatics approaches. Journal of Biomolecular Structure and Dynamics, 39(6):2133–2151, April 2020. URL: http://dx.doi.org/10.1080/07391102.2020.1745281, doi:10.1080/07391102.2020.1745281. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/07391102.2020.1745281)

[4. (De2021Rare) Eva Y. G. De Vilder, Ludovic Martin, Georges Lefthériotis, Paul Coucke, Filip Van Nieuwerburgh, and Olivier M. Vanakker. Rare modifier variants alter the severity of cardiovascular disease in pseudoxanthoma elasticum: identification of novel candidate modifier genes and disease pathways through mixture of effects analysis. Frontiers in Cell and Developmental Biology, June 2021. URL: http://dx.doi.org/10.3389/fcell.2021.612581, doi:10.3389/fcell.2021.612581. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.612581)

[5. (Jin2018Aberrant) Jinglan Jin, Hongqin Xu, Ruihong Wu, Junqi Niu, and Shibo Li. Aberrant dna methylation profile of hepatitis b virus infection. Journal of Medical Virology, 91(1):81–92, September 2018. URL: http://dx.doi.org/10.1002/jmv.25284, doi:10.1002/jmv.25284. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jmv.25284)